Read Research Alzheimer's More http://fuckalzheimers.com/2019/10/06/escitalopram-for-agitation-in-alzheimers-disease-s-citad-methods-and-design-of-an-investigator-initiated-randomized-controlled-multicenter-clinical-trial/' title='Share this by email.' class='social email'>           

Escitalopram for agitation in Alzheimer's disease (S-CitAD): Methods and design of an investigator-initiated, randomized, controlled, multicenter clinical trial

Alzheimer’s disease (AD) is a disabling, common cause of dementia, and agitation is one of the most common and distressing symptoms for patients with AD. Escitalopram for agitation in Alzheimer’s disease (S-CitAD) tests a novel, clinically derived therapeutic approach to treat agitation in patients with AD. Read & Research Alzheimer’s More

Leave a Reply